NCT00063999
Clinical Trial Information
Trial Number: NCT00063999 (ClinicalTrials.gov)
Disease Type:
- Reproductive System Neoplasm, Female - Uterine Cancer
Trial Title:
Randomized Phase III Trial of Doxorubicin/Cisplatin/Paclitaxel and G-CSF versus Carboplatin/Paclitaxel in Patients with Stage III & IV or Recurrent Endometrial Cancer
Study ID:
GOG-0209
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT00063999-D2 | There are two submissions associated with PMID 33078978. This dataset, NCT00063999-D2, contains quality of life (QOL) data from trial NCT00063999. |
| NCT00063999-D1 | There are two submissions associated with PMID 33078978. This dataset, NCT00063999-D1, contains baseline characteristics, toxicity, and clinical outcomes data in trial NCT00063999. |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®